The antiulcer and autonomic pharmacology of pyridyl-2-thioacetamide (CMN 131).
D000081:Acetamides / Q000008:administration & dosage*; D000818:Animals; D001241:Aspirin; D001341:Autonomic Nervous System / Q000187:drug effects*; D001986:Bronchial Spasm / Q000139:chemically induced / Q000188:drug therapy; D002415:Cats; D004285:Dogs; D005725:Ganglia, Autonomic / Q000187:drug effects; D005750:Gastric Juice / Q000187:drug effects / Q000378:metabolism; D006168:Guinea Pigs; D006632:Histamine; D006634:Histamine H1 Antagonists; D009541:Nictitating Membrane / Q000187:drug effects; D010275:Parasympathetic Nervous System / Q000187:drug effects; D010437:Peptic Ulcer / Q000139:chemically induced / Q000188:drug therapy*; D010653:Phenylbutazone; D011725:Pyridines / Q000008:administration & dosage; D011817:Rabbits; D051381:Rats; D012110:Reserpine; D012702:Serotonin Antagonists; D013312:Stress, Physiological; D013853:Thioacetamide / Q000008:administration & dosage
D000081:Acetamides; D006634:Histamine H1 Antagonists; D011725:Pyridines; D012702:Serotonin Antagonists; D013853:Thioacetamide; D006632:Histamine; D012110:Reserpine; D010653:Phenylbutazone; D001241:Aspirin